Pharmafile Logo
  • - PMLiVE
  • - PMLiVE
  • Diversity, Equity and Inclusion
  • Communiqué 53 Cover Image

Gower Publishing

Novartis building

Novartis says pipeline is “industry leading”

Touts 14 drug candidates with $1bn-plus sales potential

- PMLiVE

French e-health project to use near-field communication

Smartphone technology will help caregivers on home visits

- PMLiVE

Ad agency Lime takes on its first graduate trainees

Eric John and Erin O’Hare join as junior copywriter and account executive

- PMLiVE

Interview: Trevor Smith, Takeda

Takeda’s head of commercial operations for Europe and Canada talks about the integration of Nycomed and European market access

EU flag

Europe launches health plan for its ageing population

Improved adherence and greater use of telehealth named as key areas

Novartis building

Novartis’ heart failure drug serelaxin meets targets

And FDA committee backs Signifor for Cushing's disease

- PMLiVE

Lundbeck revenues fall on Lexapro competition

Reinforces need for successful vortioxetine launch

- PMLiVE

Teva promotes Allan Oberman to take over from William Marth

Executive leadership changes also see Jill DeSimone join

- PMLiVE

Watson completes Actavis acquisition, will rebrand in 2013

Will bring its global operations under the Actavis name from next year

- PMLiVE

Obama victory ensures US healthcare reforms will continue

Republican hopeful Mitt Romney unable to act on plan to repeal Affordable Care Act

- PMLiVE

Red Cross Hurricane app in top three downloads

Digital health apps prove to be highly effective and widely used

Pharma deals during October 2012

As pharma companies ramp up their activity after the summer, this month's dealmakers included Pfizer, AstraZeneca, Merck & Co and Bayer

Subscribe to our email news alerts

Latest content

Latest intelligence

Quick links